Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Total Current Liabilities (2016 - 2025)

Conmed's Total Current Liabilities history spans 16 years, with the latest figure at $315.0 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 13.27% year-over-year to $315.0 million; the TTM value through Dec 2025 reached $315.0 million, up 13.27%, while the annual FY2025 figure was $315.0 million, 13.27% up from the prior year.
  • Total Current Liabilities reached $315.0 million in Q4 2025 per CNMD's latest filing, roughly flat from $314.7 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $376.3 million in Q3 2023 to a low of $182.2 million in Q1 2021.
  • Average Total Current Liabilities over 5 years is $267.1 million, with a median of $282.7 million recorded in 2024.
  • Peak YoY movement for Total Current Liabilities: skyrocketed 80.42% in 2023, then decreased 24.98% in 2024.
  • A 5-year view of Total Current Liabilities shows it stood at $196.6 million in 2021, then surged by 50.8% to $296.6 million in 2022, then rose by 4.78% to $310.7 million in 2023, then dropped by 10.49% to $278.1 million in 2024, then grew by 13.27% to $315.0 million in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Total Current Liabilities are $315.0 million (Q4 2025), $314.7 million (Q3 2025), and $294.8 million (Q2 2025).